In vivo and in vitro assessment of baseline blood-brain barrier parameters in the presence of novel nanoparticles.
about
Drug delivery and nanoparticles:applications and hazardsThe effect of ventilation, age, and asthmatic condition on ultrafine particle deposition in childrenTargeting brain cells with glutathione-modulated nanoliposomes: in vitro and in vivo study.Strategies to overcome the barrier: use of nanoparticles as carriers and modulators of barrier properties.Surface engineering of macrophages with nanoparticles to generate a cell-nanoparticle hybrid vehicle for hypoxia-targeted drug delivery.Chronic nicotine exposure alters blood-brain barrier permeability and diminishes brain uptake of methyllycaconitine.Pharmacokinetic parameters and tissue distribution of magnetic Fe(3)O(4) nanoparticles in mice.Development of HIV reservoir targeted long acting nanoformulated antiretroviral therapiesPreliminary biocompatibility investigation of magnetic albumin nanosphere designed as a potential versatile drug delivery system.Putative proteins involved in manganese transport across the blood-brain barrier.Polymeric nanoparticles for the drug delivery to the central nervous system.P-glycoprotein mediated efflux limits substrate and drug uptake in a preclinical brain metastases of breast cancer modelMetal chelators coupled with nanoparticles as potential therapeutic agents for Alzheimer's diseaseIn vivo methods to study uptake of nanoparticles into the brain.Cellular interactions of therapeutically delivered nanoparticles.Drug delivery to the CNS and polymeric nanoparticulate carriers.Nanostructure-based drug delivery systems for brain targeting.Advances in brain drug targeting and delivery: limitations and challenges of solid lipid nanoparticles.Nanoparticles and the blood-brain barrier: advancing from in-vitro models towards therapeutic significance.The antiproliferative effect of indomethacin-loaded lipid-core nanocapsules in glioma cells is mediated by cell cycle regulation, differentiation, and the inhibition of survival pathwaysQuantitative fluorescence microscopy provides high resolution imaging of passive diffusion and P-gp mediated efflux at the in vivo blood-brain barrier.Manufactured aluminum oxide nanoparticles decrease expression of tight junction proteins in brain vasculatureRivastigmine-loaded L-lactide-depsipeptide polymeric nanoparticles: decisive formulation variable optimization.Inhibition of choline uptake by N-cyclohexylcholine, a high affinity ligand for the choline transporter at the blood-brain barrier.An Implantable Micro-Caged Device for Direct Local Delivery of Agents.Nano-ropinirole for the management of Parkinsonism: blood-brain pharmacokinetics and carrier localization.Delivery of hydrophobised 5-fluorouracil derivative to brain tissue through intravenous route using surface modified nanogels.
P2860
Q24655744-B8E8F2ED-9BAF-4A0E-AC1D-689D84416F23Q28386644-FC97051A-8737-4D9F-A147-67BD6359333DQ30406070-373B2D0F-9355-4D15-BD5A-85397D5A02C7Q30768284-B4EF5FB4-B6D3-42AA-80D8-65CA7DC81A5DQ33644844-3835CE0E-C755-4844-9C4E-2A949EE8EC8FQ33987770-A8A4D1B6-31A1-4E68-8D16-F5B6903A5A4EQ34239858-7CECD2A0-9F71-4F46-BB5D-5C7592090167Q34797004-BD2E2143-BF10-4A33-B540-78B3E03D0359Q35254404-28A2EE2B-DFDF-428B-B03A-70E16729C684Q36872157-A4DBE9B2-55D4-4169-8C1C-9BCFEB9A4E72Q37076360-71E6B547-3499-4D42-8EA3-280F87372847Q37276052-CCC54DC9-DFC6-4835-983E-DEA8A53A2841Q37428097-08844456-76AD-4DEC-95D1-A7EC2D81D4D6Q37798178-9D800E6B-21C3-40D9-9CC8-8A618CFF167AQ37827166-5E0DD885-8F5E-48FA-A34E-4DCAC452F332Q37856301-F039DE7E-720C-428D-9E58-C7C8C7C7B3F6Q37939942-15C235D5-396D-4B8B-BFB8-A163C3DD43D9Q38095485-9ECCA40F-F757-4F97-9809-C1E020397CD2Q38275050-E5875F19-EF62-497B-8F37-E620E90CE003Q39188696-46B09767-D3DA-460E-9E17-17C43705F57EQ39372353-4D73F09D-FC49-41D2-9152-F49EBCED82FDQ41830204-A92B4043-7AA5-4E8F-B3FF-78846CCA8631Q42256432-E31F04EA-095F-48FC-9CA6-574096BC692AQ46624407-BEDF0BFC-8B02-4E00-813A-3553311A7228Q47098539-34BC65F4-FAFA-4A34-9332-181B29C92E77Q48187795-5A14A56A-DED1-4610-AAA0-FD24C2955983Q48587261-9A43E5D3-46D2-44CB-8275-3BD02B7764E5
P2860
In vivo and in vitro assessment of baseline blood-brain barrier parameters in the presence of novel nanoparticles.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
In vivo and in vitro assessmen ...... esence of novel nanoparticles.
@en
In vivo and in vitro assessmen ...... esence of novel nanoparticles.
@nl
type
label
In vivo and in vitro assessmen ...... esence of novel nanoparticles.
@en
In vivo and in vitro assessmen ...... esence of novel nanoparticles.
@nl
prefLabel
In vivo and in vitro assessmen ...... esence of novel nanoparticles.
@en
In vivo and in vitro assessmen ...... esence of novel nanoparticles.
@nl
P2093
P356
P1476
In vivo and in vitro assessmen ...... esence of novel nanoparticles.
@en
P2093
David D Allen
Jennifer Paulson
Joanna Koziara
Karen E Roder
Paul R Lockman
Russell J Mumper
Thomas J Abbruscato
P304
P356
10.1023/A:1023492015851
P577
2003-05-01T00:00:00Z